Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

16th Oct 2023 08:34

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival. Read More

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

4th Oct 2023 12:14

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes. Read More

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

3rd Oct 2023 16:55

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer. Read More

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

3rd Oct 2023 11:59

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers. Read More

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

3rd Oct 2023 08:36

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million. Read More

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

3rd Oct 2023 07:41

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging. Read More

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

25th Sep 2023 09:13

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning: Read More

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

25th Sep 2023 07:43

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector. Read More

LONDON MARKET OPEN: Stocks slip after central bank rate calls

22nd Sep 2023 08:42

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions. Read More

TOP NEWS: AstraZeneca's datopotamab deruxtecan shows positive results

22nd Sep 2023 08:13

(Alliance News) - AstraZeneca PLC on Friday said phase three data showed that datopotamab deruxtecan delivered improvement in progression-free survival in breast cancer patients. Read More

TOP NEWS: AstraZeneca's rare disease business buys Pfizer portfolio

20th Sep 2023 08:44

(Alliance News) - AstraZeneca PLC on Wednesday said rare disease business Alexion has signed a purchase and licence agreement for a rare disease programme portfolio from Pfizer Inc. Read More

AstraZeneca and Daiichi Sankyo's Enhertu recommended for approval

15th Sep 2023 15:27

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd's Enhertu has been recommended for approval in the EU on Friday. Read More

Smith & Nephew brings BT Chief Financial Officer Simon Lowth to board

14th Sep 2023 08:25

(Alliance News) - Smith & Nephew PLC on Thursday announced that BT Group PLC's chief financial officer, Simon Lowth, will join the board as independent non-executive director on January 1. Read More

AstraZeneca says Fasenra therapy meets primary endpoint at trial

11th Sep 2023 21:54

(Alliance News) - AstraZeneca PLC on Monday said that its therapy, Fasenra, met the primary endpoint in the Mandara phase three trial in eosinophilic granulomatosis with polyangiitis. Read More

UPDATE: AstraZeneca has good results from three cancer drugs in trials

11th Sep 2023 10:17

(Alliance News) - AstraZeneca PLC reported positive clinical results of combinations of its Imfinzi and Tagrisso drugs with other treatments for lung cancer, while also seeing "strong and durable" tumour responses from its Enhertu antibody drug conjugate. Read More

FTSE 100 Latest

Value10,114.29

Change-81.06